<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01169246</url>
  </required_header>
  <id_info>
    <org_study_id>RTGX02-ASAP</org_study_id>
    <secondary_id>RTGX02</secondary_id>
    <nct_id>NCT01169246</nct_id>
  </id_info>
  <brief_title>Efficacy of the ATP Switch Automatic Programming in Implantable Cardioverter Defibrillator (ICD) and Cardiac Resynchronization Therapy Defibrillator (CRT-D) Implanted Patients</brief_title>
  <acronym>ASAP</acronym>
  <official_title>Efficacy of the ATP Switch Automatic Programming in ICD and CRT-D Implanted Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>LivaNova</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Sorin Group France SAS</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>LivaNova</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Primary objective is to assess the efficacy of the new ATP Autoswitch function in simple,
      dual or triple chamber ICD.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The efficacy rate of the ATP Auto-switch function, defined as the % of VT episodes
      successfully reduced, will be compared with 85%.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Low recruitement rate
  </why_stopped>
  <start_date>November 2009</start_date>
  <completion_date type="Actual">February 2015</completion_date>
  <primary_completion_date type="Actual">February 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Ventricular Tachyarrhythmia episode</measure>
    <time_frame>2 years</time_frame>
    <description>% of VT episode successfully reduced by the ATP Auto-switch</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Arrhythmia incidence</measure>
    <time_frame>2 years</time_frame>
    <description>DEvice based data</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">1254</enrollment>
  <condition>Ventricular Arrythmias</condition>
  <arm_group>
    <arm_group_label>Paradym VR, DR and CRT models</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        ICD/CRT-D implanted patients population
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The patient has been implanted (primo implantation or replacement) with an ICD model
             PARADYM VR 8250, DR 8550, CRT 8750, CRT 8770 models or any similar or higher range
             device

          -  ATP Auto-switch function is programmed ON

        Exclusion Criteria:

          -  Presence of a contra-indication to the ICD therapy

          -  Life expectancy less than 12 months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>SAVOURE Arnaud, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Rouen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHU Brest</name>
      <address>
        <city>Brest</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 22, 2010</study_first_submitted>
  <study_first_submitted_qc>July 23, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 26, 2010</study_first_posted>
  <last_update_submitted>February 23, 2015</last_update_submitted>
  <last_update_submitted_qc>February 23, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 25, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>ATP,CRT, ICD PARADYM</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

